Intended for Healthcare Professionals
You are here
Home > Blog > Endocrinology > Testosterone therapy- A clearer clinical review

Testosterone therapy- A clearer clinical review

GlobalRPh clinical tools | For healthcare professionals
Recently updated: Version 1.7

Testosterone therapy.
A clearer clinical review.

Bring the diagnostic workup, treatment options, dose calculations and follow-up review together with the updated GlobalRPh Testosterone Review, Dosing and Monitoring Platform.

Trt Clinic Exterior From The Globalrph Testosterone Therapy Blog
Built for structured clinician review in adult men.
Image from the GlobalRPh testosterone therapy blog.

Two clinical workflowsInitial evaluation and existing therapy
Product-specific guidanceFormulations, sampling and monitoring
Reports and trendsReview, download and discuss
A practical tool for a detailed clinical task

Keep the whole testosterone review in view

A testosterone result needs context: the patient’s symptoms, collection conditions, underlying diagnosis, fertility plans, treatment history and safety findings. GlobalRPh’s Testosterone Review platform helps organize those details into a structured clinical review.

The app has recently been updated to version 1.7, with expanded oral-product coverage, stronger checks for incomplete information, clearer monitoring guidance and an easier-to-read layout. It is designed for clinicians evaluating adult men with suspected testosterone deficiency or reviewing medically indicated testosterone replacement therapy.

The workflow reflects a central guideline principle: diagnosis requires appropriate clinical findings and consistently low testosterone measurements, supported by accurate testing and evaluation of the cause. [1] The app helps structure that review and shows what still needs attention before a treatment discussion proceeds.

The recent update

What’s new in version 1.7?

More detail where clinical decisions depend on it

  • Expanded oral therapy options: TLANDO and KYZATREX starting-plan examples join JATENZO, with separate product-specific sampling and monitoring instructions.
  • Clearer diagnostic confirmation: the initial review asks users to confirm separate early-morning specimens and checks optional collection dates for conflicts.
  • Stronger pretreatment checks: triggered prolactin or pituitary evaluation and elevated baseline hematocrit receive more explicit attention before a starting plan is shown.
  • More cautious follow-up interpretation: missing current testosterone, hematocrit, blood pressure or collection dates remain visible as incomplete information.
  • Updated laboratory guidance: all 18 displayed reference rows were reviewed, with corrections to zinc and selected age-specific intervals and clearer handling of calculated free testosterone.
  • Improved readability: larger text and controls, prominent source links, quick navigation, responsive tables and a refreshed hero section make the tool easier to explore.

The update also strengthens numeric and date validation, keeps vial calculations separate from other formulations, and expands the evidence and safety information available alongside the workflow.

Start with the right patient pathway

Two workflows for two different clinical questions

New or untreated patient

Organize the initial evaluation before considering a formulation or starting regimen.

  • Compatible symptoms and two morning testosterone results.
  • Collection conditions, acute illness and potentially reversible contributors.
  • LH and related endocrine testing when indicated.
  • Fertility intentions, CBC, hematocrit, blood pressure and prostate-risk context.
  • Missing information, reasons to defer and issues needing further evaluation.

When the entered information supports moving forward, the workflow offers a clinician-directed choice to start, defer or refer.

Existing patient on therapy

Review the actual treatment and the patient’s response before interpreting a laboratory change.

  • Current product, dose, route and administration frequency.
  • Adherence, technique, symptom response and adverse effects.
  • Blood-draw timing in relation to the selected formulation.
  • Baseline, first follow-up and latest entered results.
  • Testosterone, hematocrit, blood pressure and PSA review when applicable.

The results bring findings, missing items, cautions, monitoring needs and next steps into a structured review.

Two completed fictional cases are available from the opening screen: a new-patient workup and an existing patient with rising safety markers. They provide a quick way to learn how the tool responds before entering a case.

Return to top

Formulation matters

Compare treatment options with their practical differences

The platform includes formulation comparisons, selected starting examples and product-specific monitoring resources. Preference-based comparisons consider factors such as avoiding needles, daily dosing, household transfer concerns, flexibility, office visits and treatment burden. These comparisons support discussion; they do not establish that one product is medically preferable for a particular patient.

Coverage available in the app; exact product labeling remains the prescribing reference.
Formulation or product What the tool helps review
Cypionate or enanthate vials Starting examples, administration frequency, weekly totals, dose per administration, concentration and injection volume.
XYOSTED A distinct autoinjector pathway with product-specific starting and monitoring information, separate from vial arithmetic.
AndroGel 1% and 1.62% Separate topical examples, application considerations and label-specific testosterone sampling guidance.
JATENZO, TLANDO and KYZATREX Individual oral-product examples and monitoring instructions, including differences in blood-draw timing and dose-review approach.
Natesto Intranasal treatment considerations, a label-based starting example and follow-up guidance.
AVEED Long-acting injection information, administration-setting considerations and required product-specific safety precautions.
Pellets and other products Practical formulation comparisons and prompts for exact label and specialist review, without an automatically generated pellet regimen.

Direct DailyMed links and section numbers make it easier to move from the app to the official prescribing information. The monitoring guide keeps the selected product visible when reviewing when a sample should be collected and what follow-up is needed.

Make the arithmetic visible

Dose, volume and frequency tools

For supported cypionate and enanthate vial regimens, the calculator shows the relationship among the weekly total, number of administrations, dose per administration and volume in mL. Users can select a listed concentration or enter a custom concentration, and review an estimated four-week vial volume.

Frequency options include weekly and divided schedules, including every-other-day and daily examples. Optional lower-weekly-total scenarios allow clinicians to inspect the arithmetic of a deliberate adjustment. Changing frequency and changing total dose are presented as separate decisions.

Choose the volume display

View mL alone or include U-100 syringe volume markings. The app identifies those markings as a volume reference, not insulin potency units, and includes dose-measurement cautions.

Explore an illustrative curve

A normalized peak-and-trough model helps show how administration frequency can change an illustrative concentration pattern. It is an educational model, not a prediction of an individual patient’s testosterone levels.

Keep the evidence level visible. Product-label examples, guideline examples and practice-based split-dose schedules are distinguished in the app. Off-label frequency or route examples require clinician review; a smoother modeled curve does not prove better symptoms or long-term safety.

Return to top

Interpret results in context

Laboratory references and monitoring in one place

The laboratory guide contains 18 reference entries, with source links and explanations of how each test fits into the review. It separates core diagnostic and safety information from conditional testing and tests that are not routine testosterone dose targets.

The guide covers total, free and bioavailable testosterone; SHBG; LH; FSH; prolactin; estradiol; hemoglobin; hematocrit; PSA; A1c; DHT; DHEA; hs-CRP; homocysteine; zinc; and 1,25-dihydroxyvitamin D. Inclusion in the guide does not mean that every patient needs every test.

Users can enter local total-testosterone reference limits and select supported units. When the necessary inputs are available, the app provides a calculated free-testosterone estimate using total testosterone, SHBG and albumin. Version 1.7 makes the estimate’s limitations clearer and avoids treating it as interchangeable with an equilibrium-dialysis measurement.

Follow safety findings over time

The existing-patient pathway organizes entered results across three timepoints and can display testosterone and hematocrit trend graphs. PSA comparisons use an explicitly identified pretreatment baseline when available.

Keep unresolved items visible

The review highlights missing information and safety findings involving hematocrit, blood pressure, prostate evaluation, fertility and other entered risk factors. Product-specific monitoring guidance stays connected to the selected therapy.

A separate evidence and safety section links to guideline and regulatory resources. Example laboratory ranges remain subject to the reporting laboratory, assay, age and clinical context.

Take the review with you

Structured reports, trend exports and easier navigation

Both workflows generate a structured clinician report that can be viewed on screen or downloaded as a text file. The existing-patient workflow also provides a CSV export of the entered trend data for further review. A print-friendly layout supports browser printing.

Quick links move between patient context, laboratory review, treatment planning, monitoring and source material. Larger controls, expandable explanations, responsive tables and repeated return-to-top links help keep a detailed review manageable on desktop and mobile screens.

Try the updated tool

Start with an example, then work through your review

  1. Open the app and choose a new or untreated patient, or an existing patient on therapy.
  2. Try one of the completed examples to see the type of findings and report the workflow produces.
  3. Gather the relevant information: laboratory values and dates, symptoms, formulation, blood-draw timing, fertility plans and safety context.
  4. Review the findings and missing items before exploring a starting example or dose calculation.
  5. Check the linked sources and download the report when the review is complete.

Use nonidentifying case information. Do not enter names, medical-record numbers or other patient identifiers. This public educational tool is not a private medical-record system; site privacy policies and third-party services apply.

A few useful distinctions

Does the app diagnose testosterone deficiency or prescribe treatment?

No. It organizes entered information, applies review rules and presents educational treatment examples. Diagnosis, treatment selection and final verification remain the responsibility of the treating clinician.

Are the laboratory guide’s 18 tests a required panel?

No. The guide explains diagnostic, safety, conditional and nonroutine uses. The patient’s presentation and the relevant clinical guidance determine which tests are appropriate.

Does every formulation have an automatic dose calculator?

No. Vial dose-volume calculations are limited to supported cypionate and enanthate regimens. Other formulations use their own guidance, selected starting examples or prompts to review the exact label.

Who is the tool designed for?

Healthcare professionals reviewing adult men with suspected testosterone deficiency or medically indicated replacement therapy. It is not designed for pediatric care, performance enhancement, self-treatment or gender-affirming hormone therapy.

Explore the recently updated platform

Use GlobalRPh Testosterone Review v1.7 to bring the diagnostic workup, formulation discussion, dose arithmetic and follow-up findings into a clearer clinical workflow. Begin with a completed example and explore the information available at each step.

Clinical resources and scope

  1. Endocrine Society: Testosterone Therapy in Men With Hypogonadism. Diagnostic evaluation, treatment considerations and monitoring.
  2. GlobalRPh Testosterone Review, Dosing and Monitoring v1.7. Features described reflect the November 17, 2026 release, including linked product labels and laboratory references.
  3. DailyMed. Use the exact current product label; the app supplies product-specific links and section references.

Clinical decision support only. Verify the indication, local laboratory intervals, product label, route, dose, monitoring plan and patient-specific risks before acting. The tool does not replace clinical judgment or specialist evaluation.

Article prepared for GlobalRPh | Version 1.7 overview | November 17, 2026

Similar Articles

Leave a Reply


thpxl